Genetic Technologies reported AUD-5335530 in EBITDA for its fiscal semester ending in June of 2024.


Ebitda Change Date
Acasti Pharma USD -4829000 133K Sep/2024
Addus HomeCare USD 43.93M 9.47M Jun/2025
Bio Techne USD 115.58M 47.73M Jun/2025
Laboratory Of America USD 633.6M 135.6M Jun/2025
Option Care Health USD 114.02M 20.86M Jun/2025
Repligen USD 32.18M 9.36M Jun/2025
Standard Biotools USD -14279000 11.5M Jun/2025
Thermo Fisher Scientific USD 3.06B 541M Jun/2025